Human Medicines European Public Assessment Report (EPAR): Revlimid, Lenalidomide, Multiple Myeloma,Lymphoma, Mantle-Cell,Myelodysplastic Syndromes, Date of Authorisation: 14/06/2007, Revision: 37, Status: Authorised

Case Medical Research
doi 10.31525/cmr-962c32
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Case Journals

Related search

Human Medicines European Public Assessment Report (EPAR): Farydak, Panobinostat, Multiple Myeloma, Date of Authorisation: 28/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Odomzo, Sonidegib, Carcinoma, Basal Cell, Date of Authorisation: 14/08/2015, Revision: 6, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Rebetol, Ribavirin, Hepatitis C, Chronic, Date of Authorisation: 06/05/1999, Revision: 32, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Imbruvica, Ibrutinib, Lymphoma, Mantle-Cell,Leukemia, Lymphocytic, Chronic, B-Cell, Date of Authorisation: 21/10/2014, Revision: 13, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Levetiracetam Sun, Levetiracetam, Epilepsy, Date of Authorisation: 14/12/2011, Revision: 11, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Pixuvri, Pixantrone Dimaleate, Lymphoma, Non-Hodgkin, Date of Authorisation: 10/05/2012, Revision: 19, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Kentera (Previously Oxybutynin Nicobrand), Oxybutynin, Urinary Incontinence, Urge, Date of Authorisation: 15/06/2004, Revision: 16, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Intelence, Etravirine, HIV Infections, Date of Authorisation: 28/08/2008, Revision: 23, Status: Authorised

Case Medical Research
2019English

Human Medicines European Public Assessment Report (EPAR): Ventavis, Iloprost, Hypertension, Pulmonary, Date of Authorisation: 15/09/2003, Revision: 26, Status: Authorised

Case Medical Research
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy